Immunisation schedules are the result of specific reasoning about timing, coverage and disease behaviour.
Timing
Ages chosen for immune response and for when protection is needed.
Which is why some doses come early and others later.
Boosters
Additional doses maintaining protection.
Which reflects how immunity wanes for particular diseases.
Population coverage
Thresholds affecting transmission across a community.
Programme decisions
Advisory committees assessing evidence and cost effectiveness.
Which differ by country and produce different schedules.
Why schedules differ between countries
Disease prevalence, healthcare structure, cost effectiveness thresholds and manufacturing supply all differ.
Which means a country omitting a vaccine another country gives is usually making a defensible different judgement rather than an error.
Advisory committees publish their reasoning, and it is generally more detailed and more cautious than public discussion of it.
Herd protection
Coverage reducing transmission and protecting those who cannot be vaccinated.
Which is why thresholds matter.
Safety monitoring
Surveillance continuing after licensing.
Which has detected rare effects and led to schedule changes.
Catch-up programmes
Provision for those who missed doses.
A general note
This describes programme design and is not medical advice; national health services are the source for individual decisions.
What the committees actually weigh
Disease burden, vaccine efficacy and safety, duration of protection, effect on transmission, and cost against health benefit.
Which is a structured assessment published in detail.
Reading a committee's actual reasoning is considerably more informative than reading coverage of its conclusion, and the documents are public.
Supply and delivery
Cold chain, distribution and workforce.
Which constrains what is deliverable.
Uptake
Access, convenience and confidence affecting coverage.
Which programmes address separately.
Schedule changes
Programmes revised as evidence develops.
Which is the system working rather than failing.
A general note
Individual decisions should be discussed with a healthcare professional; this describes how programmes are designed.
Why programmes change over time
New vaccines become available, disease patterns shift, evidence on duration of protection accumulates, and cost effectiveness calculations move as prices change.
Which means a schedule is a current best judgement rather than a fixed answer.
Changes are frequently reported as reversals when they are the normal operation of an evidence-based process.
Travel vaccination
Recommendations based on destination and activity.
Which sit outside routine schedules.
Occupational programmes
Vaccination for specific workplace exposures.
Global programmes
Eradication and elimination efforts with different logistics.
Which have achieved remarkable results and face setbacks.
A general note
Individual medical decisions belong with a healthcare professional.
Why it is worth knowing how these things work
Most of the systems that shape ordinary life are invisible by design. Nobody explains why a parcel took an odd route, why a film left a streaming service, why a wait extended, or why a price changed between two searches.
The absence of explanation is rarely deliberate concealment. It is that the people running these systems are solving their own problems, and the reasoning behind their decisions is obvious to them and completely opaque from outside.
Understanding the mechanism does not always change what you can do about it. It does remove a category of low-grade frustration that comes from assuming something is arbitrary, unfair or aimed at you personally when it is usually none of those things.
The pattern that recurs
Across almost all of these systems, the same three things turn out to be true. The behaviour that looks irrational from outside is optimising for something the observer cannot see. The cost that seems unexplained is usually concentrated in one specific stage of the process. And the information that would resolve the confusion is generally published somewhere and read by nobody.
That last point is the most useful. Regulators, operators and industry bodies publish an enormous amount of explanatory material that answers exactly the questions people complain about not being able to get answers to. It is dry, it is not promoted, and it is free.
A note on sources
Where regulation is involved, national regulators publish the actual rules and they are generally clearer than press coverage of them. Where an industry is involved, trade publications aimed at people working in it are considerably more informative than consumer coverage.
Practices described here vary substantially between countries, and anything with legal, financial or medical consequences warrants checking against the rules that apply where you are.
The pattern that recurs
Across almost all of these systems, the same three things turn out to be true. The behaviour that looks irrational from outside is optimising for something the observer cannot see. The cost that seems unexplained is usually concentrated in one specific stage of the process. And the information that would resolve the confusion is generally published somewhere and read by nobody.
That last point is the most useful. Regulators, operators and industry bodies publish an enormous amount of explanatory material that answers exactly the questions people complain about not being able to get answers to. It is dry, it is not promoted, and it is free.